Zenas BioPharma, Inc. (ZBIO)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
24. 84
-0.56
-2.2047%
$
1.72B Market Cap
- P/E Ratio
- Div Yield
661,700 Volume
- Eps
$ 25.4
Previous Close 
Want to track ZBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Zenas BioPharma, Inc. (ZBIO) Statistics
Valuation metrics
Market Cap 1.72B
Enterprise value 1.91B
Trailing P/E (ttm) -2.83
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 1,721.02
Price/Book (mrq) 6.96
Enterprise Value/Revenue 1,914.04
Enterprise Value/EBITDA -4.19
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 768.74K
Average volume (90 days) 659.16K
Price summary
52-Week low 13.5
52-Week high 44.6
Beta -
50-Day moving average 28.52
200-Day moving average 22.05
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:2
Last split Date 24 May 2018
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -484.38%
Operating margin -475.57%
Operational effectiveness
Return on assets -0.69%
Return on equity -1.9%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.67
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.19
Total debt (mrq) -
Total Debt/Equity (mrq) 1.58
Current ratio (mrq) 9.93%
Book value per share (mrq) 3.92
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
